Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics publishing date : 2022 - 05 - 03 save search
Aclaris Therapeutics to Participate in the LifeSci Partners Immunology & Inflammation Symposium
Published: 2022-05-03 (Crawled : 15:20) - globenewswire.com
ACRS | $1.235 0.41% 37K
|
Health Technology
|
| O: -0.39%
H: 3.1%
C: 1.32%
immunology symposium therapeutics
Achilles Therapeutics to Present at Upcoming Conferences
Published: 2022-05-03 (Crawled : 01:00) - biospace.com/
ACHL | $0.8145 1.53% -0.28% 100
|
Manufacturing
|
| O: 5.43%
H: 0.0%
C: 0.0%
therapeutics
Intensity Therapeutics Announces New Clinical Data in Solid Tumors for its Lead Asset, INT230-6
Published: 2022-05-03 (Crawled : 00:00) - biospace.com/
BMY | $47.84 370K
|
Health Technology
|
| O: 0.36%
H: 0.0%
C: 0.0%
int230 therapeutics
Aquestive Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
Published: 2022-05-03 (Crawled : 22:00) - globenewswire.com
AQST | $4.0 2.04% 190K
|
Health Technology
|
| O: 1.46%
H: 4.32%
C: 2.16%
therapeutics results
Topline Data for Dazodalibep (HZN-4920) Meets Primary Endpoint in Rheumatoid Arthritis
Published: 2022-05-03 (Crawled : 21:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
hzn-4920 topline
Spero Therapeutics Announces New Strategic Direction Focusing on Advancing Promising Clinical-Stage Pipeline
Published: 2022-05-03 (Crawled : 19:00) - biospace.com/
SPRO | $1.5 2.04% 2.0% 0
|
Health Technology
|
| O: -70.53%
H: 58.0%
C: 23.33%
therapeutics
Cognition Therapeutics Presented Preclinical Findings Showing that Sigma-2 Receptor Modulators Rescue Trafficking Deficits in Retinal Pigment Epithelial Cells in Model of Dry AMD
Published: 2022-05-03 (Crawled : 19:00) - biospace.com/
CGTX | $1.9 1.8K
|
|
| O: 2.87%
H: 0.0%
C: -10.53%
preclinical therapeutics pre-clinical
Halozyme To Host First Quarter 2022 Financial Results Webcast and Conference Call
Published: 2022-05-03 (Crawled : 19:00) - prnewswire.com
HALO M | $38.1 0.21% 25K
|
Health Technology
|
| O: 0.17%
H: 1.19%
C: 0.98%
conference results
Tenaya Therapeutics to Present Preclinical Data on Gene Therapy Programs and Platform Capabilities at the American Society of Gene and Cell Therapy 25th Annual Meeting
Published: 2022-05-03 (Crawled : 18:00) - biospace.com/
TNYA | $4.3 -3.59% -3.96% 130
|
|
| O: -0.21%
H: 0.58%
C: -3.05%
preclinical therapeutics therapy platform pre-clinical
Capricor Therapeutics to Present First Quarter 2022 Financial Results and Recent Corporate Update on May 10Company to Host Conference Call, May 10, 2022, at 4:30 p.m. ET
Published: 2022-05-03 (Crawled : 14:00) - biospace.com/
CAPR | $5.485 -1.17% 9K
|
Health Technology
|
| O: 8.41%
H: 3.16%
C: -1.15%
conference therapeutics results
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-74809 for the Treatment of Idiopathic Pulmonary Fibrosis
Published: 2022-05-03 (Crawled : 13:20) - biospace.com/
PLRX | $12.86 -3.02% -3.11% 28
|
Health Technology
|
| O: 0.88%
H: 2.62%
C: -5.26%
pln-7480 treatment fda fibrosis designation therapeutics fast track designation
Levena Biopharma, A Sorrento Company, Announces Positive Clinical Data for Its Out-Licensed A166 Product Candidate, A Third-Generation Anti-HER2-ADC, In Treating Heavily Pretreated HER2-Positive Breast Cancer Patients
Published: 2022-05-03 (Crawled : 13:20) - globenewswire.com
SRNE | $0.028 1.82% -8.85% 0
|
Health Technology
|
| O: 1.85%
H: 6.06%
C: 3.03%
positive cancer license breast cancer her2- her2
Qualigen Therapeutics to Acquire Majority Stake in Diagnostics Technology Company NanoSynex
Published: 2022-05-03 (Crawled : 13:20) - globenewswire.com
QLGN | $0.2974 -0.8% -3.02% 110
|
Health Technology
|
| O: 0.0%
H: 6.81%
C: 2.63%
technology diagnostics therapeutics diagnostic
Seismic Therapeutic Appoints Maude Tessier, PhD, as Chief Business Officer
Published: 2022-05-03 (Crawled : 13:00) - biospace.com/
IKNA | $1.24 -2.36% -2.42% 0
|
Manufacturing
|
| O: -13.63%
H: 9.09%
C: 4.01%
therapeutics
Trevi Therapeutics to Present at Upcoming May Meetings
Published: 2022-05-03 (Crawled : 13:00) - biospace.com/
TRVI | $2.58 -3.19% -3.29% 0
|
Health Technology
|
| O: -7.6%
H: 9.05%
C: 4.53%
therapeutics
Voyager Therapeutics Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 2022 Annual Meeting
Published: 2022-05-03 (Crawled : 13:00) - biospace.com/
VYGR | $7.74 58K
|
Health Technology
|
| O: 4.37%
H: 7.79%
C: 7.73%
therapeutics therapy
RG6501 (OpRegen®) Phase 1/2a Clinical Results Support the Potential for OpRegen to Slow, Stop or Reverse Disease Progression in Geographic Atrophy Secondary to Age-Related Macular Degeneration
Published: 2022-05-03 (Crawled : 13:00) - biospace.com/
LCTX | $1.29 12.17% 0.0% 610
|
Health Technology
|
| O: 7.56%
H: 1.56%
C: 0.78%
rg6501 opregen disease macular potential phase 1
Capricor Therapeutics to Present First Quarter 2022 Financial Results and Recent Corporate Update on May 10
Published: 2022-05-03 (Crawled : 13:00) - globenewswire.com
CAPR | $5.485 -1.17% 9K
|
Health Technology
|
| O: 8.41%
H: 3.16%
C: -1.15%
therapeutics results
XORTX Initiates Dosing of Human Subjects in the XRX-OXY-101 Clinical TrialBridging Pharmacokinetics Study Part 1 Recruitment Completed for XRx-008 Program for Autosomal Dominant Polycystic Kidney Disease
Published: 2022-05-03 (Crawled : 12:20) - biospace.com/
XRTX | $3.5 -3.05% -3.14% 12K
|
Mining, Quarrying, and Oil and ...
|
| O: 28.45%
H: 53.69%
C: 22.82%
oxy-101 disease kidney program
Hoth Therapeutics Announces Preliminary Efficacy Findings From Phase 1b Clinical Trial with Mild to Moderate Atopic Dermatitis Patient Cohort
Published: 2022-05-03 (Crawled : 12:20) - prnewswire.com
HOTH | $1.23 2.1K
|
Health Technology
|
| O: -5.44%
H: 6.76%
C: 6.2%
dermatitis trial therapeutics phase 2b
Gainers vs Losers
| 52% | 48% |
Top 10 Gainers
AGBA | $1.44 260.0% 40M
|
Finance
BPTH | $6.25 92.9% 20M
|
Health Technology
INVO | $1.445 90.13% 2.5M
|
Health Technology
EGOX | $0.0447 39.25% 24M
|
ALRN | $5.67 33.41% 110K
|
Health Technology
HOLO | $2.765 23.44% 17M
|
BNTC | $5.91 23.13% 1.3M
|
Health Technology
XPON | $2.33 20.73% 410K
|
IMNN | $1.35 18.42% 83K
|
Manufacturing
BRSH | $0.0515 15.99% 12M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.